Haloperidol Lactate Injection Shortage

• • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 1 count, NDC 63323-0474-10
  • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00143-9501-25
  • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 10 mL vial, 1 count, NDC 00143-9502-01
  • Haloperidol lactate solution for injection, Sagent, 5 mg/mL, 1 mL vial, 10 count, NDC 25021-0806-01

• • Fresenius Kabi has haloperidol lactate injection available.
  • Hikma did not provide a reason for the shortage.
  • Mylan Institutional has haloperidol lactate injection available.
  • Sagent has haloperidol lactate injection available.

• • Haloperidol lactate injection, Fresenius Kabi, 5 mg/mL, 1 mL Simplist prefilled syringe, 24 count, NDC 76045-0737-10
  • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 1 mL vial, 25 count, NDC 63323-0474-01
  • Haloperidol lactate solution for injection, Mylan Institutional (Viatris), 5 mg/mL, 1 mL vial, 25 count, NDC 67457-0426-12

Estimated Resupply Dates

• • Fresenius Kabi has haloperidol lactate injection 5 mg/mL 10 mL vials available with short expiration dating (< 9 months).
  • Hikma has haloperidol lactate injection 5 mg/mL 1 mL vials on back order and the company cannot estimate a release date. The 5 mg/mL 10 mL vials are on intermittent back order and the company is releasing supplies as they become available.
  • Sagent has haloperidol lactate injection 5 mg/mL 1 mL vials available with short expiration dating (May 2024).